| Q34150859 | An Argonaute 2 switch regulates circulating miR-210 to coordinate hypoxic adaptation across cells |
| Q30665892 | Bioengineering silicon quantum dot theranostics using a network analysis of metabolomic and proteomic data in cardiac ischemia |
| Q42318959 | Cardiomyocyte mitochondria as targets of humoral factors released by remote ischemic preconditioning |
| Q39032510 | Cardioprotection by remote ischemic conditioning and its signal transduction |
| Q37017785 | Cardioprotective Effect of Extended Remote Ischemic Preconditioning in Patients Coronary Artery Bypass Grafting Undergoing: A Randomized Clinical Trial |
| Q33712409 | Clinically-relevant consecutive treatment with isoproterenol and adenosine protects the failing heart against ischaemia and reperfusion |
| Q38722304 | Ischaemic conditioning and reperfusion injury. |
| Q37776473 | Meniere's disease: update of etiopathogenetic theories and proposal of a possible model of explanation |
| Q41369796 | Mitochondrial ATP-Sensitive Potassium Channels Play a Role in Reducing Both Myocardial Infarction and Reperfusion Arrhythmia in Remote Ischemic Preconditioned Hearts |
| Q33535020 | Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial |
| Q34631989 | Remote ischemic preconditioning of cardiomyocytes inhibits the mitochondrial permeability transition pore independently of reduced calcium-loading or sarcKATP channel activation |
| Q26830560 | Role of the MPTP in conditioning the heart - translatability and mechanism |
| Q35718978 | Serum from patients undergoing remote ischemic preconditioning protects cultured human intestinal cells from hypoxia-induced damage: involvement of matrixmetalloproteinase-2 and -9. |
| Q38234977 | The Delay Phenomenon: A Compilation of Knowledge across Specialties |
| Q37625397 | Translation of remote ischaemic preconditioning into clinical practice |